Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Director/PDMR Shareholding

27 Oct 2017 17:15

RNS Number : 8910U
Quixant PLC
27 October 2017
 

Quixant plc

("Quixant" or the "Company")

 

Issue of Equity and Director/PDMR Shareholding

 

Quixant (AIM: QXT), a leading provider of specialised computing platforms for gaming and slot machine applications and accessories, today announces that it has applied to the London Stock Exchange for 105,000 ordinary shares of £0.001 pence each in the Company ("Ordinary Shares") to be admitted to trading on AIM ("Admission"). The new Ordinary Shares are being issued subsequent to exercises of options over Ordinary Shares ("Options") by certain Directors', persons discharging managerial responsibilities ("PDMR's") and employees of the Company.

 

On 27 October 2017, Cresten Preddy, Finance Director of the Company, exercised Options on 10,000 Ordinary Shares. On Admission Cresten Preddy will hold 40,000 Ordinary Shares, representing approximately 0.06% of the Company's issued share capital.

 

Furthermore, on 27 October 2017 the following PDMR's of the Company exercised Options and subsequently sold Ordinary Shares (in certain cases) as follows:

 

PDMR

Role

Options exercised

Ordinary Shares subsequently sold

John Malin

Sales Director, Quixant UK Ltd

5,000

5,000

Sandra Lowman

Operations Director, Quixant UK Ltd

33,000

-

Amit Sharma

Vice President Sales & General Manager, Quixant USA Inc

18,000

18,000

 

Total Voting Rights

It is expected that Admission will become effective and trading will commence in the new Ordinary Shares at 8.00 a.m. on 2 November 2017. On Admission the Company's issued share capital will comprise 66,034,982 Ordinary Shares. The Company holds no Ordinary Shares in treasury. Accordingly, the figure of 66,034,982 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information please contact:

 

Quixant plc

Tel: +44 (0)1223 892 696

Jon Jayal, Chief Operating Officer

Nominated Adviser and Broker:

Tel: +44 (0)20 7220 0500

finnCap

Matt Goode / Grant Bergman (Corporate Finance)

Simon Johnson / Alice Lane (Corporate Broking)

Financial PR:

Alma PR

Tel: +44 (0)20 8004 4217

John Coles

Hilary Buchanan

Susie Hudson

 

 

About Quixant

Quixant, founded in 2005, designs and manufactures highly optimised computing solutions and monitors principally for the global gaming industry. The Company is headquartered in Cambridge in the UK where the global sales function is based. North America sales and sales support is run from their subsidiary in Las Vegas. Quixant has its own manufacturing and engineering operation based in Taiwan and software engineering and customer support team based in Italy. All the specialised products software and manufacturing are produced in-house and Quixant owns all its own IP much of which is copyright protected.

 

In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a strong heritage in the sale of electronic display solutions to global industrial markets. Through Densitron's experienced sales team, Quixant has a robust platform to build its business into wider industrial markets.

 

In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

- Cresten Preddy - Finance Director

- John Malin - Sales Director, Quixant UK Ltd

- Sandra Lowman - Operations Director, Quixant UK Ltd

- Amit Sharma - Vice President Sales & General Manager, Quixant USA Inc

2.

Reason for the notification

a)

Position/status:

PDMR's

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Quixant plc

 

b)

LEI:

2138003VERWSQP561X71

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

 

Identification code:

Ordinary Shares of £0.001

 

 

GB00B99PCP71

 

b)

Nature of the transaction:

Exercise of Options over Ordinary Shares

c)

Price(s) and volume(s):

- Cresten Preddy

Price(s)

Volume(s)

49 pence

10,000

 

- John Malin

Price(s)

Volume(s)

49 pence

5,000

 

- Sandra Lowman

Price(s)

Volume(s)

49 pence

33,000

 

- Amit Sharma

Price(s)

Volume(s)

49 pence

18,000

d)

Aggregated information:

· Aggregated volume:

· Price:

See 4(c) above

e)

Date of the transaction:

27 October 2017

 

f)

Place of the transaction:

London Stock Exchange, AIM Market (XLON)

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

- John Malin - Sales Director, Quixant UK Ltd

- Amit Sharma - Vice President Sales & General Manager, Quixant USA Inc

2.

Reason for the notification

a)

Position/status:

PDMR's

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Quixant plc

 

b)

LEI:

2138003VERWSQP561X71

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

 

Identification code:

Ordinary Shares of £0.001

 

 

GB00B99PCP71

 

b)

Nature of the transaction:

Sale of Ordinary Shares

c)

Price(s) and volume(s):

- John Malin

Price(s)

Volume(s)

£4.458254 pence

5,000

 

- Amit Sharma

Price(s)

Volume(s)

£4.458254 pence

18,000

d)

Aggregated information:

· Aggregated volume:

· Price:

See 4(c) above

e)

Date of the transaction:

27 October 2017

 

f)

Place of the transaction:

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEMMMZGVNGGNZM
Date   Source Headline
27th Apr 20234:53 pmRNSResult of AGM
27th Apr 20237:00 amRNSAGM Statement and Proposed Name Change
14th Apr 20237:00 amRNSExercise of options
4th Apr 20237:00 amRNSReport and Accounts and Notice of AGM
3rd Apr 20235:52 pmRNSHolding(s) in Company
27th Mar 20237:00 amRNSGrant of Options
21st Mar 20237:00 amRNSFinal Results
21st Feb 20237:00 amRNSNotice of Results and Investor Presentation
17th Jan 20238:15 amRNSExercise of options
16th Jan 20237:00 amRNSTrading Update and Notice of Results
13th Jan 20238:59 amRNSHolding(s) in Company
3rd Nov 202212:09 pmRNSDirector Shareholding
26th Oct 20228:20 amRNSDirector Shareholding
14th Oct 20227:23 amRNSHolding(s) in Company
13th Oct 20227:00 amRNSTrading Update
13th Sep 20227:00 amRNSAppointment of Non-Executive Directors
6th Sep 20227:00 amRNSInterim Results
1st Sep 20227:00 amRNSMass production order for gaming cabinet solutions
31st Aug 20227:00 amRNSNotice of Results and Presentations
14th Jul 20227:00 amRNSTrading Update and Notice of Results
9th May 20226:04 pmRNSGrant of Options
5th May 202211:55 amRNSResult of AGM
5th May 20227:00 amRNSAGM Statement
11th Apr 202211:37 amRNSReport and Accounts and Notice of AGM
5th Apr 20227:00 amRNSFinal Results
18th Mar 20227:00 amRNSNotice of Results and Presentations
9th Mar 20222:06 pmRNSSecond Price Monitoring Extn
9th Mar 20222:00 pmRNSPrice Monitoring Extension
13th Jan 20227:00 amRNSTrading Update and Notice of Results
29th Oct 20212:28 pmRNSGrant of Options
22nd Sep 20217:00 amRNSInterim Results
15th Sep 20217:00 amRNSInvestor Presentation
5th Aug 202111:16 amRNSHolding(s) in Company
29th Jul 20217:00 amRNSTrading Update and Notice of Results
12th Jul 20213:02 pmRNSHolding(s) in Company
8th Jul 20217:00 amRNSAppointment of CFO
1st Jul 20217:00 amRNSDirector Shareholding
6th May 20215:12 pmRNSResult of AGM
6th May 20217:00 amRNSAGM Statement
19th Apr 20216:07 pmRNSHolding(s) in Company
19th Apr 20215:48 pmRNSHolding(s) in Company
14th Apr 20217:00 amRNSFinal Results
9th Apr 20214:40 pmRNSRescheduled Investor Presentation
9th Apr 20213:41 pmRNSAnnouncement of Final Results
6th Apr 20217:00 amRNSInvestor Presentation
26th Feb 20217:00 amRNSNotice of Results
12th Feb 20217:00 amRNSAppointment of Joint Broker
27th Jan 20217:00 amRNSTrading Update and Notice of Results
15th Jan 20217:00 amRNSAppointment of New Senior Independent NED
10th Dec 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.